<?xml version="1.0" encoding="UTF-8"?>
<ref id="b21-1031835">
 <label>21.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mahon</surname>
    <given-names>FX</given-names>
   </name>
   <name>
    <surname>Boquimpani</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>DW</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase: results from a single-group, phase 2, open-label study</article-title>. 
  <source>Ann Intern Med</source>. 
  <year>2018</year>;
  <volume>168</volume>(
  <issue>7</issue>):
  <fpage>461</fpage>â€“
  <lpage>470</lpage>.
  <pub-id pub-id-type="pmid">29459949</pub-id>
 </mixed-citation>
</ref>
